시장보고서
상품코드
1885177

소화불량 치료제 시장 분석 및 예측(-2034년) : 유형, 제품, 용도, 최종 사용자, 형태, 기술, 배포, 기능성

Dyspepsia Drugs Market Analysis and Forecast to 2034: Type, Product, Application, End User, Form, Technology, Deployment, Functionality

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 377 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

소화불량 치료제 시장은 2024년 107억 달러에서 2034년까지 172억 달러로 확대되어 CAGR 약 5.2%를 나타낼 것으로 예측됩니다. 소화불량 치료제 시장은 팽만감, 메스꺼움, 불쾌감 등 소화불량 증상을 완화하기 위한 의약품을 포함하고 있습니다. 이 시장에는 제산제, H2 차단제, 위장관 운동 촉진제, 양성자 펌프 억제제가 포함됩니다. 위장질환의 유병률 상승과 더불어 의식의 향상과 헬스케어 접근의 향상으로 시장 성장이 촉진되고 있습니다. 혁신은 효능 향상, 부작용 완화, 암멧 필요에 대한 대응에 초점을 맞추고 있으며, 경쟁 차별화와 치료 옵션의 확대를 추진하고 있습니다.

소화불량 치료제 시장은 위장 질환 증가 경향과 생활 양식의 변화를 배경으로 현저한 성장을 이루고 있습니다. 양성자 펌프 억제제(PPI) 부문은 위산 분비 억제 및 증상 완화에서 효능에서 가장 높은 성장률을 보여줍니다. 이어서 높은 성장률을 나타내는 H2 수용체 길항제 분절은 산분비 억제의 대체 메커니즘을 제공합니다. 시판약(OTC)은 입수 용이성과 자기 치료 지향의 고조로부터 인기를 모으고 있습니다. 그러나 의료 감독이 필요한 만성 소화불량 사례를 배경으로 처방약은 여전히 확고한 지위를 유지하고 있습니다. 복수의 작용 경로를 표적으로 함으로써 효과를 높이는 병용 요법 수요가 증가하고 있습니다. 서방형 제제나 씹을 수 있는 정제 등 약제제제의 혁신도 시장 성장을 더욱 촉진하고 있습니다. 자연 요법과 허브 요법에 대한 관심 증가는 보다 안전하고 부작용이 적은 선택을 요구하는 소비자층에게 새로운 기회를 제시합니다. 이러한 요인의 시너지 효과는 시장 상황이 역동적 인 전개를 보이고 있으며 미래의 확대 가능성이 매우 큰 것으로 나타났습니다.

시장 세분화
유형별 프로톤 펌프 억제제, H2 수용체 길항제, 제산제, 운동 촉진제
제품 처방약, 시판약, 제네릭 의약품, 브랜드 의약품
적응증 위식도 역류질환(GERD), 위궤양, 기능성 소화불량증, 비궤양성 소화불량증
최종 사용자 병원, 진료소, 재택치료 시설, 외래수술센터(ASC)
투약 형태 정제, 캡슐, 액체, 분말
기술 나노기술, 생명공학, 약물유전체학
배포 입원환자, 외래환자
기능 산분비 억제, 운동성 촉진, 점막 보호

소화불량 치료제 시장에서는 주요 제약 회사가 혁신적인 제품을 투입하는 동안 시장 점유율의 역동적 인 변화를 볼 수 있습니다. 기업은 우위를 다투고 약물의 효능과 환자 컴플라이언스 향상을 활용하는 경쟁력있는 가격 전략을 개발하고 있습니다. 소비자가 더 효과적이고 편리한 치료법을 추구하는 동안, 신규 제제 및 전달 메커니즘의 도입은 시장 성장을 더욱 촉진하고 있습니다. 이 진화하는 상황은 시장 점유율을 얻기 위해 전략적 제품 투입과 가격 모델의 중요성을 돋보이게합니다. 경쟁 벤치마킹 분야에서는 주요 기업들이 합병·인수를 통해 포트폴리오를 강화하고 활발한 경쟁 환경을 조성하고 있습니다. 규제의 영향은 매우 중요하며 엄격한 승인 프로세스가 시장 진입과 확대에 영향을 미칩니다. 시장은 확립된 대기업부터 신흥 혁신기업까지 다양한 기업을 특징으로 하며, 각사가 복잡한 규제 상황을 탐구하고 있습니다. 경쟁과 규제의 상호작용은 시장 역학을 형성하고 성장과 혁신을 위한 과제와 기회를 모두 제공합니다.

세계의 소화불량 치료제 시장은 관세, 지정학적 위험, 진화하는 공급망의 동향에 크게 영향을 받고 있습니다. 일본과 한국은 의약품의 혁신을 촉진하고 수입 의존도를 줄임으로써 무역 마찰을 극복하려고 노력하고 있습니다. 중국은 수출 규제의 영향을 완화하기 위해 국내 의약품 제조 능력에 대한 투자를 추진하고 있으며, 대만은 지정 학적 압력에 노출되면서도 의약품 성분 분야에서 중요한 역할을 계속하고 있습니다. 상위 시장은 고령화와 건강 관리 의식 증가를 배경으로 꾸준한 성장을 이루고 있습니다. 2035년까지 지역간 협력의 강화와 약물전달 시스템의 기술 진보에 의해 시장은 진화할 것으로 예측됩니다. 반면 중동 분쟁은 에너지 가격에 압력을 가하고 있으며, 이는 간접적으로 제약 업계 전체의 생산 비용과 공급망의 안정성에 영향을 미칩니다.

주요 동향과 성장 촉진요인 :

소화기 질환의 유병률 증가와 소화기 건강에 대한 의식 향상을 배경으로 소화불량 치료제 시장은 현저한 성장을 이루고 있습니다. 주요 동향은 효능과 환자 컴플라이언스의 향상을 목표로 하는 고급 약물 제제의 개발을 포함합니다. 서방형 정제나 액제와 같은 신규 전달 시스템의 도입이 진행되어, 치료 효과의 개선이 도모되고 있습니다. 또한 소비자가 소화불량 증상의 신속하고 간편한 완화를 요구하는 가운데 시판약(OTC의약품)에 대한 수요가 급증하고 있습니다. 이러한 추세는 정보에 대한 접근성과 온라인 플랫폼의 보급에 의해 촉진되는 자기 치료 지향 증가와 함께 진행되고 있습니다. 또한 신흥국의 건강 관리 인프라 확장은 시장 관계자에게 유리한 기회를 제공합니다. 각 회사는 제품 포트폴리오 확대 및 시장 존재 강화를 위해 전략적 제휴 및 파트너십에 주력하고 있습니다. 맞춤형 의료 및 표적 요법의 도입 확대도 시장 성장을 더욱 촉진하고 있습니다. 특정 요구를 가진 환자에게 개별적으로 조정된 치료 접근을 가능하게 하기 위해서입니다.

목차

제1장 소화불량 치료제 시장 개요

  • 조사 목적
  • 소화불량 치료제 시장 : 보고서의 정의와 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 기간 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 소화불량 치료제 시장 전망

  • 소화불량 치료제 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTEL 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 소화불량 치료제 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 소화불량 치료제 시장 규모

  • 소화불량 치료제 시장 규모(금액 기준)
  • 소화불량 치료제 시장 규모(수량 기준)

제7장 소화불량 치료제 시장 : 유형별

  • 프로톤 펌프 억제제
  • H2 수용체 길항제
  • 제산제
  • 운동 촉진제
  • 기타

제8장 소화불량 치료제 시장 : 제품별

  • 처방약
  • 일반의약품
  • 제네릭 의약품
  • 브랜드 의약품
  • 기타

제9장 소화불량 치료제 시장 : 용도별

  • 위식도 역류질환(GERD)
  • 위궤양
  • 기능성 소화불량증
  • 비궤양성 소화불량증
  • 기타

제10장 소화불량 치료제 시장 : 최종 사용자별

  • 병원
  • 진료소
  • 재택치료 시설
  • 외래수술센터(ASC)
  • 기타

제11장 소화불량 치료제 시장 : 폼별

  • 정제
  • 캡슐
  • 액상 제제
  • 분말 제제
  • 기타

제12장 소화불량 치료제 시장 : 기술별

  • 나노기술
  • 생명공학
  • 약물 유전체학
  • 기타

제13장 소화불량 치료제 시장 : 배포별

  • 입원환자
  • 외래환자
  • 기타

제14장 소화불량 치료제 시장 : 기능별

  • 산분비 억제
  • 운동성 증진
  • 점막 보호
  • 기타

제15장 소화불량 치료제 시장 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제16장 경쟁 구도

  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 공급업체 벤치마킹
  • 개발 전략 벤치마킹

제17장 기업 프로파일

  • Ironwood Pharmaceuticals
  • Phathom Pharmaceuticals
  • RedHill Biopharma
  • Ardelyx
  • Pharmaxis
  • Sucampo Pharmaceuticals
  • RaQualia Pharma
  • Daewoong Pharmaceutical
  • Kyowa Kirin
  • Eisai Co
  • Astellas Pharma
  • Tsumura & Co
  • Zeria Pharmaceutical
  • Shionogi & Co
  • Sumitomo Pharma
  • Nippon Shinyaku
  • Mochida Pharmaceutical
  • Asahi Kasei Pharma
  • Kissei Pharmaceutical
  • Maruho
KTH 25.12.18

Dyspepsia Drugs Market is anticipated to expand from $10.7 billion in 2024 to $17.2 billion by 2034, growing at a CAGR of approximately 5.2%. The Dyspepsia Drugs Market encompasses pharmaceuticals aimed at alleviating symptoms of indigestion, such as bloating, nausea, and discomfort. This market includes antacids, H2 blockers, prokinetics, and proton pump inhibitors. Rising prevalence of gastrointestinal disorders, coupled with increasing awareness and healthcare access, propels market growth. Innovations focus on enhancing efficacy, reducing side effects, and addressing unmet medical needs, driving competitive differentiation and expanding therapeutic options.

The Dyspepsia Drugs Market is experiencing notable growth, propelled by an increasing prevalence of gastrointestinal disorders and lifestyle changes. The proton pump inhibitors (PPIs) segment is the top-performing category, owing to their effectiveness in reducing stomach acid and providing symptomatic relief. H2 receptor antagonists follow as the second highest-performing segment, offering an alternative mechanism for acid reduction. Over-the-counter (OTC) medications are gaining popularity due to their accessibility and growing consumer preference for self-medication. Prescription-based drugs, however, maintain a strong foothold, driven by chronic dyspepsia cases requiring medical supervision. The demand for combination therapies is rising, as they offer enhanced efficacy by targeting multiple pathways. Innovations in drug formulations, such as extended-release and chewable tablets, are further augmenting market growth. The increasing focus on natural and herbal remedies presents an emerging opportunity, as consumers seek safer, side-effect-free options. This convergence of factors underscores a dynamic market landscape with significant potential for future expansion.

Market Segmentation
TypeProton Pump Inhibitors, H2 Receptor Antagonists, Antacids, Prokinetics
ProductPrescription Drugs, Over-the-Counter Drugs, Generic Drugs, Brand Drugs
ApplicationGastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease, Functional Dyspepsia, Non-Ulcer Dyspepsia
End UserHospitals, Clinics, Home Care Settings, Ambulatory Surgical Centers
FormTablets, Capsules, Liquid Formulations, Powder Formulations
TechnologyNanotechnology, Biotechnology, Pharmacogenomics
DeploymentIn-Patient, Out-Patient
FunctionalityAcid Reduction, Motility Enhancement, Mucosal Protection

The Dyspepsia Drugs Market is witnessing a dynamic shift in market share, with major pharmaceutical companies launching innovative products. Competitive pricing strategies are evident as firms vie for dominance, leveraging advancements in drug efficacy and patient compliance. The introduction of novel formulations and delivery mechanisms further propels market growth, as consumers seek more effective and convenient treatment options. This evolving landscape underscores the importance of strategic product launches and pricing models in capturing market share. In the realm of competition benchmarking, leading companies are enhancing their portfolios through mergers and acquisitions, fostering a robust competitive environment. Regulatory influences play a pivotal role, with stringent approval processes impacting market entry and expansion. The market is characterized by a diverse range of players, from established giants to emerging innovators, each navigating the complex regulatory landscape. The interplay of competition and regulation shapes the market dynamics, offering both challenges and opportunities for growth and innovation.

Geographical Overview:

The dyspepsia drugs market is witnessing diverse growth across global regions, each presenting unique opportunities. North America maintains a dominant position due to advanced healthcare infrastructure and high prevalence of digestive disorders. The region's focus on innovative drug development and personalized medicine further bolsters market expansion. Europe is closely following, driven by increased healthcare spending and a growing geriatric population susceptible to dyspepsia. Asia Pacific is emerging as a lucrative growth pocket, supported by rising healthcare awareness and economic development. Countries like China and India are leading this surge, with expanding pharmaceutical industries and increasing healthcare access. Latin America is also showcasing potential with improving healthcare systems and increasing prevalence of gastrointestinal disorders. The Middle East & Africa, though currently smaller in market size, are gradually recognizing the importance of addressing digestive health, thus paving the way for future growth in the dyspepsia drugs market.

The global dyspepsia drugs market is significantly influenced by tariffs, geopolitical risks, and evolving supply chain dynamics. Japan and South Korea are navigating trade tensions by fostering pharmaceutical innovation and reducing dependency on imports. China is investing in domestic drug manufacturing capabilities to mitigate the impact of export restrictions, while Taiwan remains a pivotal player in pharmaceutical components, albeit exposed to geopolitical pressures. The parent market is experiencing steady growth, driven by an aging population and rising healthcare awareness. By 2035, the market is expected to evolve with increased regional collaboration and technological advancements in drug delivery systems. Meanwhile, Middle East conflicts are exerting pressure on energy prices, which indirectly affects production costs and supply chain stability across the pharmaceutical sector.

Key Trends and Drivers:

The Dyspepsia Drugs Market is experiencing notable growth, driven by increasing prevalence of gastrointestinal disorders and rising awareness about digestive health. Key trends include the development of advanced drug formulations, aiming to enhance efficacy and patient compliance. The integration of novel delivery systems, such as extended-release tablets and liquid formulations, is gaining traction, offering improved therapeutic outcomes. Moreover, the market is witnessing a surge in demand for over-the-counter (OTC) medications, as consumers seek convenient and immediate relief from dyspepsia symptoms. This trend is complemented by the growing inclination towards self-medication, fueled by easy access to information and online platforms. Additionally, the expansion of healthcare infrastructure in emerging economies is providing lucrative opportunities for market players. Companies are focusing on strategic collaborations and partnerships to expand their product portfolios and strengthen their market presence. The increasing adoption of personalized medicine and targeted therapies is further propelling market growth, as it enables tailored treatment approaches for patients with specific needs.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Dyspepsia Drugs Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Dyspepsia Drugs Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by End User
  • 2.7 Key Highlights of the Market, by Form
  • 2.8 Key Highlights of the Market, by Technology
  • 2.9 Key Highlights of the Market, by Deployment
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by North America
  • 2.12 Key Highlights of the Market, by Europe
  • 2.13 Key Highlights of the Market, by Asia-Pacific
  • 2.14 Key Highlights of the Market, by Latin America
  • 2.15 Key Highlights of the Market, by Middle East
  • 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by End User
  • 3.6 Market Attractiveness Analysis, by Form
  • 3.7 Market Attractiveness Analysis, by Technology
  • 3.8 Market Attractiveness Analysis, by Deployment
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by North America
  • 3.11 Market Attractiveness Analysis, by Europe
  • 3.12 Market Attractiveness Analysis, by Asia-Pacific
  • 3.13 Market Attractiveness Analysis, by Latin America
  • 3.14 Market Attractiveness Analysis, by Middle East
  • 3.15 Market Attractiveness Analysis, by Africa

4: Dyspepsia Drugs Market Outlook

  • 4.1 Dyspepsia Drugs Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Dyspepsia Drugs Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Dyspepsia Drugs Market Size

  • 6.1 Dyspepsia Drugs Market Size, by Value
  • 6.2 Dyspepsia Drugs Market Size, by Volume

7: Dyspepsia Drugs Market, by Type

  • 7.1 Market Overview
  • 7.2 Proton Pump Inhibitors
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 H2 Receptor Antagonists
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Antacids
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Prokinetics
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Others
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region

8: Dyspepsia Drugs Market, by Product

  • 8.1 Market Overview
  • 8.2 Prescription Drugs
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Over-the-Counter Drugs
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Generic Drugs
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Brand Drugs
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Dyspepsia Drugs Market, by Application

  • 9.1 Market Overview
  • 9.2 Gastroesophageal Reflux Disease (GERD)
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Peptic Ulcer Disease
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Functional Dyspepsia
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Non-Ulcer Dyspepsia
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Dyspepsia Drugs Market, by End User

  • 10.1 Market Overview
  • 10.2 Hospitals
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Clinics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Home Care Settings
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Ambulatory Surgical Centers
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Dyspepsia Drugs Market, by Form

  • 11.1 Market Overview
  • 11.2 Tablets
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Capsules
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Liquid Formulations
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Powder Formulations
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Dyspepsia Drugs Market, by Technology

  • 12.1 Market Overview
  • 12.2 Nanotechnology
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Pharmacogenomics
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Dyspepsia Drugs Market, by Deployment

  • 13.1 Market Overview
  • 13.2 In-Patient
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Out-Patient
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Dyspepsia Drugs Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Acid Reduction
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Motility Enhancement
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Mucosal Protection
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Dyspepsia Drugs Market, by Region

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 Key Market Trends and Opportunities
    • 15.2.2 North America Market Size and Forecast, by Type
    • 15.2.3 North America Market Size and Forecast, by Product
    • 15.2.4 North America Market Size and Forecast, by Application
    • 15.2.5 North America Market Size and Forecast, by End User
    • 15.2.6 North America Market Size and Forecast, by Form
    • 15.2.7 North America Market Size and Forecast, by Technology
    • 15.2.8 North America Market Size and Forecast, by Deployment
    • 15.2.9 North America Market Size and Forecast, by Functionality
    • 15.2.10 North America Market Size and Forecast, by Country
    • 15.2.11 United States
      • 15.2.9.1 United States Market Size and Forecast, by Type
      • 15.2.9.2 United States Market Size and Forecast, by Product
      • 15.2.9.3 United States Market Size and Forecast, by Application
      • 15.2.9.4 United States Market Size and Forecast, by End User
      • 15.2.9.5 United States Market Size and Forecast, by Form
      • 15.2.9.6 United States Market Size and Forecast, by Technology
      • 15.2.9.7 United States Market Size and Forecast, by Deployment
      • 15.2.9.8 United States Market Size and Forecast, by Functionality
      • 15.2.9.9 Local Competition Analysis
      • 15.2.9.10 Local Market Analysis
    • 15.2.1 Canada
      • 15.2.10.1 Canada Market Size and Forecast, by Type
      • 15.2.10.2 Canada Market Size and Forecast, by Product
      • 15.2.10.3 Canada Market Size and Forecast, by Application
      • 15.2.10.4 Canada Market Size and Forecast, by End User
      • 15.2.10.5 Canada Market Size and Forecast, by Form
      • 15.2.10.6 Canada Market Size and Forecast, by Technology
      • 15.2.10.7 Canada Market Size and Forecast, by Deployment
      • 15.2.10.8 Canada Market Size and Forecast, by Functionality
      • 15.2.10.9 Local Competition Analysis
      • 15.2.10.10 Local Market Analysis
  • 15.1 Europe
    • 15.3.1 Key Market Trends and Opportunities
    • 15.3.2 Europe Market Size and Forecast, by Type
    • 15.3.3 Europe Market Size and Forecast, by Product
    • 15.3.4 Europe Market Size and Forecast, by Application
    • 15.3.5 Europe Market Size and Forecast, by End User
    • 15.3.6 Europe Market Size and Forecast, by Form
    • 15.3.7 Europe Market Size and Forecast, by Technology
    • 15.3.8 Europe Market Size and Forecast, by Deployment
    • 15.3.9 Europe Market Size and Forecast, by Functionality
    • 15.3.10 Europe Market Size and Forecast, by Country
    • 15.3.11 United Kingdom
      • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 15.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 15.3.9.4 United Kingdom Market Size and Forecast, by End User
      • 15.3.9.5 United Kingdom Market Size and Forecast, by Form
      • 15.3.9.6 United Kingdom Market Size and Forecast, by Technology
      • 15.3.9.7 United Kingdom Market Size and Forecast, by Deployment
      • 15.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 15.3.9.9 Local Competition Analysis
      • 15.3.9.10 Local Market Analysis
    • 15.3.1 Germany
      • 15.3.10.1 Germany Market Size and Forecast, by Type
      • 15.3.10.2 Germany Market Size and Forecast, by Product
      • 15.3.10.3 Germany Market Size and Forecast, by Application
      • 15.3.10.4 Germany Market Size and Forecast, by End User
      • 15.3.10.5 Germany Market Size and Forecast, by Form
      • 15.3.10.6 Germany Market Size and Forecast, by Technology
      • 15.3.10.7 Germany Market Size and Forecast, by Deployment
      • 15.3.10.8 Germany Market Size and Forecast, by Functionality
      • 15.3.10.9 Local Competition Analysis
      • 15.3.10.10 Local Market Analysis
    • 15.3.1 France
      • 15.3.11.1 France Market Size and Forecast, by Type
      • 15.3.11.2 France Market Size and Forecast, by Product
      • 15.3.11.3 France Market Size and Forecast, by Application
      • 15.3.11.4 France Market Size and Forecast, by End User
      • 15.3.11.5 France Market Size and Forecast, by Form
      • 15.3.11.6 France Market Size and Forecast, by Technology
      • 15.3.11.7 France Market Size and Forecast, by Deployment
      • 15.3.11.8 France Market Size and Forecast, by Functionality
      • 15.3.11.9 Local Competition Analysis
      • 15.3.11.10 Local Market Analysis
    • 15.3.1 Spain
      • 15.3.12.1 Spain Market Size and Forecast, by Type
      • 15.3.12.2 Spain Market Size and Forecast, by Product
      • 15.3.12.3 Spain Market Size and Forecast, by Application
      • 15.3.12.4 Spain Market Size and Forecast, by End User
      • 15.3.12.5 Spain Market Size and Forecast, by Form
      • 15.3.12.6 Spain Market Size and Forecast, by Technology
      • 15.3.12.7 Spain Market Size and Forecast, by Deployment
      • 15.3.12.8 Spain Market Size and Forecast, by Functionality
      • 15.3.12.9 Local Competition Analysis
      • 15.3.12.10 Local Market Analysis
    • 15.3.1 Italy
      • 15.3.13.1 Italy Market Size and Forecast, by Type
      • 15.3.13.2 Italy Market Size and Forecast, by Product
      • 15.3.13.3 Italy Market Size and Forecast, by Application
      • 15.3.13.4 Italy Market Size and Forecast, by End User
      • 15.3.13.5 Italy Market Size and Forecast, by Form
      • 15.3.13.6 Italy Market Size and Forecast, by Technology
      • 15.3.13.7 Italy Market Size and Forecast, by Deployment
      • 15.3.13.8 Italy Market Size and Forecast, by Functionality
      • 15.3.13.9 Local Competition Analysis
      • 15.3.13.10 Local Market Analysis
    • 15.3.1 Netherlands
      • 15.3.14.1 Netherlands Market Size and Forecast, by Type
      • 15.3.14.2 Netherlands Market Size and Forecast, by Product
      • 15.3.14.3 Netherlands Market Size and Forecast, by Application
      • 15.3.14.4 Netherlands Market Size and Forecast, by End User
      • 15.3.14.5 Netherlands Market Size and Forecast, by Form
      • 15.3.14.6 Netherlands Market Size and Forecast, by Technology
      • 15.3.14.7 Netherlands Market Size and Forecast, by Deployment
      • 15.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 15.3.14.9 Local Competition Analysis
      • 15.3.14.10 Local Market Analysis
    • 15.3.1 Sweden
      • 15.3.15.1 Sweden Market Size and Forecast, by Type
      • 15.3.15.2 Sweden Market Size and Forecast, by Product
      • 15.3.15.3 Sweden Market Size and Forecast, by Application
      • 15.3.15.4 Sweden Market Size and Forecast, by End User
      • 15.3.15.5 Sweden Market Size and Forecast, by Form
      • 15.3.15.6 Sweden Market Size and Forecast, by Technology
      • 15.3.15.7 Sweden Market Size and Forecast, by Deployment
      • 15.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 15.3.15.9 Local Competition Analysis
      • 15.3.15.10 Local Market Analysis
    • 15.3.1 Switzerland
      • 15.3.16.1 Switzerland Market Size and Forecast, by Type
      • 15.3.16.2 Switzerland Market Size and Forecast, by Product
      • 15.3.16.3 Switzerland Market Size and Forecast, by Application
      • 15.3.16.4 Switzerland Market Size and Forecast, by End User
      • 15.3.16.5 Switzerland Market Size and Forecast, by Form
      • 15.3.16.6 Switzerland Market Size and Forecast, by Technology
      • 15.3.16.7 Switzerland Market Size and Forecast, by Deployment
      • 15.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 15.3.16.9 Local Competition Analysis
      • 15.3.16.10 Local Market Analysis
    • 15.3.1 Denmark
      • 15.3.17.1 Denmark Market Size and Forecast, by Type
      • 15.3.17.2 Denmark Market Size and Forecast, by Product
      • 15.3.17.3 Denmark Market Size and Forecast, by Application
      • 15.3.17.4 Denmark Market Size and Forecast, by End User
      • 15.3.17.5 Denmark Market Size and Forecast, by Form
      • 15.3.17.6 Denmark Market Size and Forecast, by Technology
      • 15.3.17.7 Denmark Market Size and Forecast, by Deployment
      • 15.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 15.3.17.9 Local Competition Analysis
      • 15.3.17.10 Local Market Analysis
    • 15.3.1 Finland
      • 15.3.18.1 Finland Market Size and Forecast, by Type
      • 15.3.18.2 Finland Market Size and Forecast, by Product
      • 15.3.18.3 Finland Market Size and Forecast, by Application
      • 15.3.18.4 Finland Market Size and Forecast, by End User
      • 15.3.18.5 Finland Market Size and Forecast, by Form
      • 15.3.18.6 Finland Market Size and Forecast, by Technology
      • 15.3.18.7 Finland Market Size and Forecast, by Deployment
      • 15.3.18.8 Finland Market Size and Forecast, by Functionality
      • 15.3.18.9 Local Competition Analysis
      • 15.3.18.10 Local Market Analysis
    • 15.3.1 Russia
      • 15.3.19.1 Russia Market Size and Forecast, by Type
      • 15.3.19.2 Russia Market Size and Forecast, by Product
      • 15.3.19.3 Russia Market Size and Forecast, by Application
      • 15.3.19.4 Russia Market Size and Forecast, by End User
      • 15.3.19.5 Russia Market Size and Forecast, by Form
      • 15.3.19.6 Russia Market Size and Forecast, by Technology
      • 15.3.19.7 Russia Market Size and Forecast, by Deployment
      • 15.3.19.8 Russia Market Size and Forecast, by Functionality
      • 15.3.19.9 Local Competition Analysis
      • 15.3.19.10 Local Market Analysis
    • 15.3.1 Rest of Europe
      • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 15.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 15.3.20.4 Rest of Europe Market Size and Forecast, by End User
      • 15.3.20.5 Rest of Europe Market Size and Forecast, by Form
      • 15.3.20.6 Rest of Europe Market Size and Forecast, by Technology
      • 15.3.20.7 Rest of Europe Market Size and Forecast, by Deployment
      • 15.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 15.3.20.9 Local Competition Analysis
      • 15.3.20.10 Local Market Analysis
  • 15.1 Asia-Pacific
    • 15.4.1 Key Market Trends and Opportunities
    • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 15.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 15.4.5 Asia-Pacific Market Size and Forecast, by End User
    • 15.4.6 Asia-Pacific Market Size and Forecast, by Form
    • 15.4.7 Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.8 Asia-Pacific Market Size and Forecast, by Deployment
    • 15.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
    • 15.4.11 China
      • 15.4.9.1 China Market Size and Forecast, by Type
      • 15.4.9.2 China Market Size and Forecast, by Product
      • 15.4.9.3 China Market Size and Forecast, by Application
      • 15.4.9.4 China Market Size and Forecast, by End User
      • 15.4.9.5 China Market Size and Forecast, by Form
      • 15.4.9.6 China Market Size and Forecast, by Technology
      • 15.4.9.7 China Market Size and Forecast, by Deployment
      • 15.4.9.8 China Market Size and Forecast, by Functionality
      • 15.4.9.9 Local Competition Analysis
      • 15.4.9.10 Local Market Analysis
    • 15.4.1 India
      • 15.4.10.1 India Market Size and Forecast, by Type
      • 15.4.10.2 India Market Size and Forecast, by Product
      • 15.4.10.3 India Market Size and Forecast, by Application
      • 15.4.10.4 India Market Size and Forecast, by End User
      • 15.4.10.5 India Market Size and Forecast, by Form
      • 15.4.10.6 India Market Size and Forecast, by Technology
      • 15.4.10.7 India Market Size and Forecast, by Deployment
      • 15.4.10.8 India Market Size and Forecast, by Functionality
      • 15.4.10.9 Local Competition Analysis
      • 15.4.10.10 Local Market Analysis
    • 15.4.1 Japan
      • 15.4.11.1 Japan Market Size and Forecast, by Type
      • 15.4.11.2 Japan Market Size and Forecast, by Product
      • 15.4.11.3 Japan Market Size and Forecast, by Application
      • 15.4.11.4 Japan Market Size and Forecast, by End User
      • 15.4.11.5 Japan Market Size and Forecast, by Form
      • 15.4.11.6 Japan Market Size and Forecast, by Technology
      • 15.4.11.7 Japan Market Size and Forecast, by Deployment
      • 15.4.11.8 Japan Market Size and Forecast, by Functionality
      • 15.4.11.9 Local Competition Analysis
      • 15.4.11.10 Local Market Analysis
    • 15.4.1 South Korea
      • 15.4.12.1 South Korea Market Size and Forecast, by Type
      • 15.4.12.2 South Korea Market Size and Forecast, by Product
      • 15.4.12.3 South Korea Market Size and Forecast, by Application
      • 15.4.12.4 South Korea Market Size and Forecast, by End User
      • 15.4.12.5 South Korea Market Size and Forecast, by Form
      • 15.4.12.6 South Korea Market Size and Forecast, by Technology
      • 15.4.12.7 South Korea Market Size and Forecast, by Deployment
      • 15.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 15.4.12.9 Local Competition Analysis
      • 15.4.12.10 Local Market Analysis
    • 15.4.1 Australia
      • 15.4.13.1 Australia Market Size and Forecast, by Type
      • 15.4.13.2 Australia Market Size and Forecast, by Product
      • 15.4.13.3 Australia Market Size and Forecast, by Application
      • 15.4.13.4 Australia Market Size and Forecast, by End User
      • 15.4.13.5 Australia Market Size and Forecast, by Form
      • 15.4.13.6 Australia Market Size and Forecast, by Technology
      • 15.4.13.7 Australia Market Size and Forecast, by Deployment
      • 15.4.13.8 Australia Market Size and Forecast, by Functionality
      • 15.4.13.9 Local Competition Analysis
      • 15.4.13.10 Local Market Analysis
    • 15.4.1 Singapore
      • 15.4.14.1 Singapore Market Size and Forecast, by Type
      • 15.4.14.2 Singapore Market Size and Forecast, by Product
      • 15.4.14.3 Singapore Market Size and Forecast, by Application
      • 15.4.14.4 Singapore Market Size and Forecast, by End User
      • 15.4.14.5 Singapore Market Size and Forecast, by Form
      • 15.4.14.6 Singapore Market Size and Forecast, by Technology
      • 15.4.14.7 Singapore Market Size and Forecast, by Deployment
      • 15.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 15.4.14.9 Local Competition Analysis
      • 15.4.14.10 Local Market Analysis
    • 15.4.1 Indonesia
      • 15.4.15.1 Indonesia Market Size and Forecast, by Type
      • 15.4.15.2 Indonesia Market Size and Forecast, by Product
      • 15.4.15.3 Indonesia Market Size and Forecast, by Application
      • 15.4.15.4 Indonesia Market Size and Forecast, by End User
      • 15.4.15.5 Indonesia Market Size and Forecast, by Form
      • 15.4.15.6 Indonesia Market Size and Forecast, by Technology
      • 15.4.15.7 Indonesia Market Size and Forecast, by Deployment
      • 15.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 15.4.15.9 Local Competition Analysis
      • 15.4.15.10 Local Market Analysis
    • 15.4.1 Taiwan
      • 15.4.16.1 Taiwan Market Size and Forecast, by Type
      • 15.4.16.2 Taiwan Market Size and Forecast, by Product
      • 15.4.16.3 Taiwan Market Size and Forecast, by Application
      • 15.4.16.4 Taiwan Market Size and Forecast, by End User
      • 15.4.16.5 Taiwan Market Size and Forecast, by Form
      • 15.4.16.6 Taiwan Market Size and Forecast, by Technology
      • 15.4.16.7 Taiwan Market Size and Forecast, by Deployment
      • 15.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 15.4.16.9 Local Competition Analysis
      • 15.4.16.10 Local Market Analysis
    • 15.4.1 Malaysia
      • 15.4.17.1 Malaysia Market Size and Forecast, by Type
      • 15.4.17.2 Malaysia Market Size and Forecast, by Product
      • 15.4.17.3 Malaysia Market Size and Forecast, by Application
      • 15.4.17.4 Malaysia Market Size and Forecast, by End User
      • 15.4.17.5 Malaysia Market Size and Forecast, by Form
      • 15.4.17.6 Malaysia Market Size and Forecast, by Technology
      • 15.4.17.7 Malaysia Market Size and Forecast, by Deployment
      • 15.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 15.4.17.9 Local Competition Analysis
      • 15.4.17.10 Local Market Analysis
    • 15.4.1 Rest of Asia-Pacific
      • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 15.4.18.9 Local Competition Analysis
      • 15.4.18.10 Local Market Analysis
  • 15.1 Latin America
    • 15.5.1 Key Market Trends and Opportunities
    • 15.5.2 Latin America Market Size and Forecast, by Type
    • 15.5.3 Latin America Market Size and Forecast, by Product
    • 15.5.4 Latin America Market Size and Forecast, by Application
    • 15.5.5 Latin America Market Size and Forecast, by End User
    • 15.5.6 Latin America Market Size and Forecast, by Form
    • 15.5.7 Latin America Market Size and Forecast, by Technology
    • 15.5.8 Latin America Market Size and Forecast, by Deployment
    • 15.5.9 Latin America Market Size and Forecast, by Functionality
    • 15.5.10 Latin America Market Size and Forecast, by Country
    • 15.5.11 Brazil
      • 15.5.9.1 Brazil Market Size and Forecast, by Type
      • 15.5.9.2 Brazil Market Size and Forecast, by Product
      • 15.5.9.3 Brazil Market Size and Forecast, by Application
      • 15.5.9.4 Brazil Market Size and Forecast, by End User
      • 15.5.9.5 Brazil Market Size and Forecast, by Form
      • 15.5.9.6 Brazil Market Size and Forecast, by Technology
      • 15.5.9.7 Brazil Market Size and Forecast, by Deployment
      • 15.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 15.5.9.9 Local Competition Analysis
      • 15.5.9.10 Local Market Analysis
    • 15.5.1 Mexico
      • 15.5.10.1 Mexico Market Size and Forecast, by Type
      • 15.5.10.2 Mexico Market Size and Forecast, by Product
      • 15.5.10.3 Mexico Market Size and Forecast, by Application
      • 15.5.10.4 Mexico Market Size and Forecast, by End User
      • 15.5.10.5 Mexico Market Size and Forecast, by Form
      • 15.5.10.6 Mexico Market Size and Forecast, by Technology
      • 15.5.10.7 Mexico Market Size and Forecast, by Deployment
      • 15.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 15.5.10.9 Local Competition Analysis
      • 15.5.10.10 Local Market Analysis
    • 15.5.1 Argentina
      • 15.5.11.1 Argentina Market Size and Forecast, by Type
      • 15.5.11.2 Argentina Market Size and Forecast, by Product
      • 15.5.11.3 Argentina Market Size and Forecast, by Application
      • 15.5.11.4 Argentina Market Size and Forecast, by End User
      • 15.5.11.5 Argentina Market Size and Forecast, by Form
      • 15.5.11.6 Argentina Market Size and Forecast, by Technology
      • 15.5.11.7 Argentina Market Size and Forecast, by Deployment
      • 15.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 15.5.11.9 Local Competition Analysis
      • 15.5.11.10 Local Market Analysis
    • 15.5.1 Rest of Latin America
      • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 15.5.12.4 Rest of Latin America Market Size and Forecast, by End User
      • 15.5.12.5 Rest of Latin America Market Size and Forecast, by Form
      • 15.5.12.6 Rest of Latin America Market Size and Forecast, by Technology
      • 15.5.12.7 Rest of Latin America Market Size and Forecast, by Deployment
      • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 15.5.12.9 Local Competition Analysis
      • 15.5.12.10 Local Market Analysis
  • 15.1 Middle East and Africa
    • 15.6.1 Key Market Trends and Opportunities
    • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 15.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 15.6.5 Middle East and Africa Market Size and Forecast, by End User
    • 15.6.6 Middle East and Africa Market Size and Forecast, by Form
    • 15.6.7 Middle East and Africa Market Size and Forecast, by Technology
    • 15.6.8 Middle East and Africa Market Size and Forecast, by Deployment
    • 15.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
    • 15.6.11 Saudi Arabia
      • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 15.6.9.4 Saudi Arabia Market Size and Forecast, by End User
      • 15.6.9.5 Saudi Arabia Market Size and Forecast, by Form
      • 15.6.9.6 Saudi Arabia Market Size and Forecast, by Technology
      • 15.6.9.7 Saudi Arabia Market Size and Forecast, by Deployment
      • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 15.6.9.9 Local Competition Analysis
      • 15.6.9.10 Local Market Analysis
    • 15.6.1 UAE
      • 15.6.10.1 UAE Market Size and Forecast, by Type
      • 15.6.10.2 UAE Market Size and Forecast, by Product
      • 15.6.10.3 UAE Market Size and Forecast, by Application
      • 15.6.10.4 UAE Market Size and Forecast, by End User
      • 15.6.10.5 UAE Market Size and Forecast, by Form
      • 15.6.10.6 UAE Market Size and Forecast, by Technology
      • 15.6.10.7 UAE Market Size and Forecast, by Deployment
      • 15.6.10.8 UAE Market Size and Forecast, by Functionality
      • 15.6.10.9 Local Competition Analysis
      • 15.6.10.10 Local Market Analysis
    • 15.6.1 South Africa
      • 15.6.11.1 South Africa Market Size and Forecast, by Type
      • 15.6.11.2 South Africa Market Size and Forecast, by Product
      • 15.6.11.3 South Africa Market Size and Forecast, by Application
      • 15.6.11.4 South Africa Market Size and Forecast, by End User
      • 15.6.11.5 South Africa Market Size and Forecast, by Form
      • 15.6.11.6 South Africa Market Size and Forecast, by Technology
      • 15.6.11.7 South Africa Market Size and Forecast, by Deployment
      • 15.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 15.6.11.9 Local Competition Analysis
      • 15.6.11.10 Local Market Analysis
    • 15.6.1 Rest of MEA
      • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 15.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 15.6.12.4 Rest of MEA Market Size and Forecast, by End User
      • 15.6.12.5 Rest of MEA Market Size and Forecast, by Form
      • 15.6.12.6 Rest of MEA Market Size and Forecast, by Technology
      • 15.6.12.7 Rest of MEA Market Size and Forecast, by Deployment
      • 15.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 15.6.12.9 Local Competition Analysis
      • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

  • 16.1 Overview
  • 16.2 Market Share Analysis
  • 16.3 Key Player Positioning
  • 16.4 Competitive Leadership Mapping
    • 16.4.1 Star Players
    • 16.4.2 Innovators
    • 16.4.3 Emerging Players
  • 16.5 Vendor Benchmarking
  • 16.6 Developmental Strategy Benchmarking
    • 16.6.1 New Product Developments
    • 16.6.2 Product Launches
    • 16.6.3 Business Expansions
    • 16.6.4 Partnerships, Joint Ventures, and Collaborations
    • 16.6.5 Mergers and Acquisitions

17: Company Profiles

  • 17.1 Ironwood Pharmaceuticals
    • 17.1.1 Company Overview
    • 17.1.2 Company Snapshot
    • 17.1.3 Business Segments
    • 17.1.4 Business Performance
    • 17.1.5 Product Offerings
    • 17.1.6 Key Developmental Strategies
    • 17.1.7 SWOT Analysis
  • 17.2 Phathom Pharmaceuticals
    • 17.2.1 Company Overview
    • 17.2.2 Company Snapshot
    • 17.2.3 Business Segments
    • 17.2.4 Business Performance
    • 17.2.5 Product Offerings
    • 17.2.6 Key Developmental Strategies
    • 17.2.7 SWOT Analysis
  • 17.3 RedHill Biopharma
    • 17.3.1 Company Overview
    • 17.3.2 Company Snapshot
    • 17.3.3 Business Segments
    • 17.3.4 Business Performance
    • 17.3.5 Product Offerings
    • 17.3.6 Key Developmental Strategies
    • 17.3.7 SWOT Analysis
  • 17.4 Ardelyx
    • 17.4.1 Company Overview
    • 17.4.2 Company Snapshot
    • 17.4.3 Business Segments
    • 17.4.4 Business Performance
    • 17.4.5 Product Offerings
    • 17.4.6 Key Developmental Strategies
    • 17.4.7 SWOT Analysis
  • 17.5 Pharmaxis
    • 17.5.1 Company Overview
    • 17.5.2 Company Snapshot
    • 17.5.3 Business Segments
    • 17.5.4 Business Performance
    • 17.5.5 Product Offerings
    • 17.5.6 Key Developmental Strategies
    • 17.5.7 SWOT Analysis
  • 17.6 Sucampo Pharmaceuticals
    • 17.6.1 Company Overview
    • 17.6.2 Company Snapshot
    • 17.6.3 Business Segments
    • 17.6.4 Business Performance
    • 17.6.5 Product Offerings
    • 17.6.6 Key Developmental Strategies
    • 17.6.7 SWOT Analysis
  • 17.7 RaQualia Pharma
    • 17.7.1 Company Overview
    • 17.7.2 Company Snapshot
    • 17.7.3 Business Segments
    • 17.7.4 Business Performance
    • 17.7.5 Product Offerings
    • 17.7.6 Key Developmental Strategies
    • 17.7.7 SWOT Analysis
  • 17.8 Daewoong Pharmaceutical
    • 17.8.1 Company Overview
    • 17.8.2 Company Snapshot
    • 17.8.3 Business Segments
    • 17.8.4 Business Performance
    • 17.8.5 Product Offerings
    • 17.8.6 Key Developmental Strategies
    • 17.8.7 SWOT Analysis
  • 17.9 Kyowa Kirin
    • 17.9.1 Company Overview
    • 17.9.2 Company Snapshot
    • 17.9.3 Business Segments
    • 17.9.4 Business Performance
    • 17.9.5 Product Offerings
    • 17.9.6 Key Developmental Strategies
    • 17.9.7 SWOT Analysis
  • 17.10 Eisai Co
    • 17.10.1 Company Overview
    • 17.10.2 Company Snapshot
    • 17.10.3 Business Segments
    • 17.10.4 Business Performance
    • 17.10.5 Product Offerings
    • 17.10.6 Key Developmental Strategies
    • 17.10.7 SWOT Analysis
  • 17.11 Astellas Pharma
    • 17.11.1 Company Overview
    • 17.11.2 Company Snapshot
    • 17.11.3 Business Segments
    • 17.11.4 Business Performance
    • 17.11.5 Product Offerings
    • 17.11.6 Key Developmental Strategies
    • 17.11.7 SWOT Analysis
  • 17.12 Tsumura & Co
    • 17.12.1 Company Overview
    • 17.12.2 Company Snapshot
    • 17.12.3 Business Segments
    • 17.12.4 Business Performance
    • 17.12.5 Product Offerings
    • 17.12.6 Key Developmental Strategies
    • 17.12.7 SWOT Analysis
  • 17.13 Zeria Pharmaceutical
    • 17.13.1 Company Overview
    • 17.13.2 Company Snapshot
    • 17.13.3 Business Segments
    • 17.13.4 Business Performance
    • 17.13.5 Product Offerings
    • 17.13.6 Key Developmental Strategies
    • 17.13.7 SWOT Analysis
  • 17.14 Shionogi & Co
    • 17.14.1 Company Overview
    • 17.14.2 Company Snapshot
    • 17.14.3 Business Segments
    • 17.14.4 Business Performance
    • 17.14.5 Product Offerings
    • 17.14.6 Key Developmental Strategies
    • 17.14.7 SWOT Analysis
  • 17.15 Sumitomo Pharma
    • 17.15.1 Company Overview
    • 17.15.2 Company Snapshot
    • 17.15.3 Business Segments
    • 17.15.4 Business Performance
    • 17.15.5 Product Offerings
    • 17.15.6 Key Developmental Strategies
    • 17.15.7 SWOT Analysis
  • 17.16 Nippon Shinyaku
    • 17.16.1 Company Overview
    • 17.16.2 Company Snapshot
    • 17.16.3 Business Segments
    • 17.16.4 Business Performance
    • 17.16.5 Product Offerings
    • 17.16.6 Key Developmental Strategies
    • 17.16.7 SWOT Analysis
  • 17.17 Mochida Pharmaceutical
    • 17.17.1 Company Overview
    • 17.17.2 Company Snapshot
    • 17.17.3 Business Segments
    • 17.17.4 Business Performance
    • 17.17.5 Product Offerings
    • 17.17.6 Key Developmental Strategies
    • 17.17.7 SWOT Analysis
  • 17.18 Asahi Kasei Pharma
    • 17.18.1 Company Overview
    • 17.18.2 Company Snapshot
    • 17.18.3 Business Segments
    • 17.18.4 Business Performance
    • 17.18.5 Product Offerings
    • 17.18.6 Key Developmental Strategies
    • 17.18.7 SWOT Analysis
  • 17.19 Kissei Pharmaceutical
    • 17.19.1 Company Overview
    • 17.19.2 Company Snapshot
    • 17.19.3 Business Segments
    • 17.19.4 Business Performance
    • 17.19.5 Product Offerings
    • 17.19.6 Key Developmental Strategies
    • 17.19.7 SWOT Analysis
  • 17.20 Maruho
    • 17.20.1 Company Overview
    • 17.20.2 Company Snapshot
    • 17.20.3 Business Segments
    • 17.20.4 Business Performance
    • 17.20.5 Product Offerings
    • 17.20.6 Key Developmental Strategies
    • 17.20.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제